C2 C Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

C2 C Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$692.45 - $844.37 $155,801 - $189,983	-225 Reduced 15.79%	1,200 $987,000
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $140,006 - $166,070	-200 Reduced 12.31%	1,425 $1.02 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $1.11 Million - $1.34 Million	1,625 New	1,625 $1.34 Million
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $238,048 - $279,372	-400 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$543.48 - $670.97 $217,392 - $268,388	400 New	400 $253,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on C2 C Wealth Management, LLC with notifications on news.